Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
Don't Overlook These Top Medical Stocks as Q1 Earnings Approach
by Shaun Pruitt
Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.
LGNDPositive Net Change PENPositive Net Change OSCRPositive Net Change
earnings investing medical medical-devices
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
PetIQ's (PETQ) first-quarter results are likely to reflect growth in the Product and Services segments of the business.
ALCNegative Net Change BPMCNegative Net Change ADVMNegative Net Change PETQPositive Net Change
medical medical-devices
Will These 5 Medical Device Stocks Beat This Earnings Season?
by Zacks Equity Research
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
MCKPositive Net Change FMSNegative Net Change INGNNegative Net Change NVROPositive Net Change INSPNegative Net Change
earnings medical medical-devices
Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?
by Riya Anand
SNDL's (SNDL) first-quarter performance is expected to benefit from reduced cost expenses and expansion into the liquor retail segment.
ALCNegative Net Change GRTSPositive Net Change SNDLNegative Net Change ERASPositive Net Change
earnings medical medical-devices
McKesson (MCK) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
McKesson's (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
MCKPositive Net Change ALCNegative Net Change FMSNegative Net Change RDNTNegative Net Change
medical medical-devices
Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y
by Zacks Equity Research
Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.
OMINegative Net Change OMCLNegative Net Change MEDPPositive Net Change EHCPositive Net Change
earnings medical medical-devices
Avanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change AVNSNegative Net Change
earnings medical medical-devices
Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
by Zacks Equity Research
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change SRDXPositive Net Change
earnings medical medical-devices
Hologic's (HOLX) Q2 Earnings Beat Estimates, 2024 View Up
by Zacks Equity Research
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
BSXPositive Net Change ALGNNegative Net Change RMDNegative Net Change HOLXPositive Net Change
earnings medical medical-devices
Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up
by Zacks Equity Research
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
BSXPositive Net Change ALGNNegative Net Change RMDNegative Net Change LNTHNegative Net Change
earnings medical medical-devices
DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up
by Zacks Equity Research
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
BSXPositive Net Change DVAPositive Net Change ALGNNegative Net Change RMDNegative Net Change
earnings medical medical-devices
Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline
by Zacks Equity Research
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.
BSXPositive Net Change ALGNNegative Net Change RMDNegative Net Change BRKRNegative Net Change
earnings medical medical-devices
GE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment
by Zacks Equity Research
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change GEHCPositive Net Change
artificial-intelligence medical-devices messenger-rna oncology-screening
Illumina (ILMN) Q1 Earnings Beat, Adjusted Operating Loss Widens
by Zacks Equity Research
Illumina (ILMN) surpasses expectations in the first quarter in a challenging global macroeconomic environment.
ILMNNegative Net Change MEDPPositive Net Change EHCPositive Net Change TMDXPositive Net Change
earnings medical medical-devices
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
by Zacks Equity Research
Tandem Diabetes (TNDM) outperforms in the first quarter, backed by the demand for both t:slim X2 and the newly launched Tandem Mobi.
TNDMPositive Net Change MEDPPositive Net Change EHCPositive Net Change TMDXPositive Net Change
earnings medical medical-devices
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change XRAYNegative Net Change
earnings medical medical-devices
Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
BSXPositive Net Change ALGNNegative Net Change RMDNegative Net Change NVSTNegative Net Change
earnings medical medical-devices
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
by Zacks Equity Research
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
BSXPositive Net Change DGXPositive Net Change ALGNNegative Net Change RMDNegative Net Change
medical medical-devices
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
by Zacks Equity Research
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change CAHPositive Net Change
earnings medical medical-devices
Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
by Zacks Equity Research
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
BSXPositive Net Change ECLPositive Net Change BAXPositive Net Change ALGNNegative Net Change
earnings medical medical-devices
BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
by Zacks Equity Research
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
BSXPositive Net Change BDXNegative Net Change ALGNNegative Net Change RMDNegative Net Change
earnings medical medical-devices
Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
by Zacks Equity Research
Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results.
BSXPositive Net Change ARAYNegative Net Change ALGNNegative Net Change RMDNegative Net Change
earnings medical medical-devices
Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change GKOSNegative Net Change
earnings medical medical-devices
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
by Zacks Equity Research
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
DGXPositive Net Change RMDNegative Net Change HCAPositive Net Change MEDPPositive Net Change
medical medical-devices
Here's Why You Should Retain STERIS (STE) Stock for Now
by Zacks Equity Research
STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.
BSXPositive Net Change HCAPositive Net Change STEPositive Net Change INSPNegative Net Change
medical medical-devices